Feminai

Company Overview

Snapshot

Founded in January 2023 by Karny Ilan, Gal Yanuka, and Shani Klein, Feminai operates with 1–10 employees. The company has raised $6M across two funding rounds from six investors, including lead investor Vertex Ventures Israel. In January 2026, Feminai secured $6M in Seed funding.

Business overview

Feminai is a Health Tech & Life Sciences company focused on developing solutions for early breast cancer detection. The company's core offering is a home breast cancer screening device integrated with a personalized AI-based medical screening plan. Feminai serves the women's health market, operating within the diagnostics devices and medical devices sectors, leveraging artificial intelligence.

Strategic signal

In January 2026, Feminai successfully raised $6M in Seed funding, a significant validation of its AI-powered at-home breast cancer screening technology. This capital infusion, led by Vertex Ventures Israel, signals strong investor confidence in Feminai's potential to innovate within the femtech and digital healthcare sectors, accelerating the development and market entry of its diagnostic solutions.

Company Intelligence Q&A

When was Feminai founded and by whom?

Feminai was founded in January 2023 by co-founders Karny Ilan, Gal Yanuka, and Shani Klein.

What significant funding did Feminai receive recently?

In January 2026, Feminai raised $6M in Seed funding. This round was led by Vertex Ventures Israel and included participation from Fusion Fund.

Has Feminai received any grants?

In October 2025, Feminai secured a grant from the Israel Innovation Authority.

What was a notable early achievement for Feminai?

In January 2023, Feminai's home breast cancer screening kit was recognized as the winning invention at the BizTEC entrepreneurship competition finals.